Chylomicron: Difference between revisions
Rim Halaby (talk | contribs) (Rim Halaby moved page Chylomicron to Chylomicron physiology) |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{High density lipoprotein}} | |||
{{CMG}}; {{AE}} {{AN}}; {{RT}} | |||
== [Chylomicron overview|Overview]] == | |||
== [Chylomicron historical perspective|Historical Perspective]] == | |||
== [Chylomicron classification|Classification]] == | |||
== [Chylomicron biochemistry|Biochemistry]] == | |||
== [Chylomicron physiology|Physiology]] == | |||
== Clinical Correlation== | |||
===[[High Chylomicron]]=== | |||
[[High Chylomicron epidemiology and demographics|Epidemiology and Demographics]] | [[High Chylomicron pathophysiology|Pathophysiology]] | [[High Chylomicron causes|Causes]] | [[High Chylomicron diseases|Diseases]] | [[High Chylomicron prognosis and complications|Prognosis and Complications]] | |||
===[[Low Chylomicron]]=== | |||
[[Low Chylomicron epidemiology and demographics|Epidemiology and Demographics]] | [[Low Chylomicron pathophysiology|Pathophysiology]] | [[Low Chylomicron causes|Causes]] | [[Low Chylomicron diseases|Diseases]] | [[Low Chylomicron prognosis and complications|Prognosis and Complications]] | |||
== Treatment == | |||
[Chylomicron medical therapy|Medical Therapy]] | [Chylomicron primary prevention|Primary Prevention]] | [Chylomicron secondary prevention|Secondary Prevention]] | [Chylomicron landmark trials|Landmark Trials]] | [Chylomicron future or investigational therapies|Future or Investigational Therapies]] | |||
{{Lipoproteins}} | |||
[[Category:Lipid disorders]] | |||
[[Category:Cardiology]] | |||
[[Category:Lipoproteins]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 17:03, 12 September 2013
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
Chylomicron On the Web |
|
American Roentgen Ray Society Images of Chylomicron |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
[Chylomicron overview|Overview]]
[Chylomicron historical perspective|Historical Perspective]]
[Chylomicron classification|Classification]]
[Chylomicron biochemistry|Biochemistry]]
[Chylomicron physiology|Physiology]]
Clinical Correlation
High Chylomicron
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low Chylomicron
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
[Chylomicron medical therapy|Medical Therapy]] | [Chylomicron primary prevention|Primary Prevention]] | [Chylomicron secondary prevention|Secondary Prevention]] | [Chylomicron landmark trials|Landmark Trials]] | [Chylomicron future or investigational therapies|Future or Investigational Therapies]]